A woeful tale of ex-Pfizer chief Jeff Kindler

Ex-CEO Jeff Kindler's quick departure from Pfizer's helm may have been dramatic, but it was nothing compared to the ups and downs of his tenure. According to Fortune's well-worth-reading saga, Kindler was a second-guessing, temper-losing, midnight-calling micro-manager. No wonder current chief Ian Read threatened to leave. Report

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.